Arcellx (ACLX) Revenue (2023 - 2025)

Arcellx's (ACLX) quarterly Revenue came in at $1.7 million in Q4 2025, down 88.96% year-on-year from $15.3 million in Q4 2024, and down 65.93% quarter-over-quarter from $4.9 million in Q3 2025.

Arcellx (ACLX) Revenue (2023 - 2025) Analysis & Trends

Arcellx's Revenue history runs 3 years deep, the most recent figure standing at $1.7 million for Q4 2025.

  • On a quarterly basis, Revenue fell 88.96% year-over-year to $1.7 million in Q4 2025; TTM through Dec 2025 was $22.4 million, a 79.28% decrease from a year earlier, with the FY2025 full-year figure at $22.3 million, down 79.35% from the prior year.
  • Revenue retreated to $1.7 million in Q4 2025 per ACLX's latest filing, from $4.9 million in the prior quarter.
  • Across five years, Revenue topped out at $63.1 million in Q4 2023 and bottomed at $1.7 million in Q4 2025.
  • The 3-year median for Revenue is $15.1 million (2023), against an average of $20.1 million.
  • Across the five-year window, Revenue jumped 119.16% in 2024 and tumbled 88.96% in 2025, its largest moves.
  • Year by year, Revenue stood at $63.1 million in 2023, then plunged by 75.83% to $15.3 million in 2024, then tumbled by 88.96% to $1.7 million in 2025.
  • Per Business Quant, the three latest ACLX Revenue figures stand at $1.7 million (Q4 2025), $4.9 million (Q3 2025), and $7.6 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.51 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 2.99 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 3.61 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 1.30 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Arcellx 6.48 Bn 6.48 Bn - 1.69 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.69 Mn
Sep 30, 2025 4.95 Mn
Jun 30, 2025 7.60 Mn
Mar 31, 2025 8.13 Mn
Dec 31, 2024 15.27 Mn
Sep 30, 2024 26.03 Mn
Jun 30, 2024 27.38 Mn
Mar 31, 2024 39.26 Mn
Dec 31, 2023 63.15 Mn
Sep 30, 2023 14.96 Mn
Jun 30, 2023 14.30 Mn
Mar 31, 2023 17.91 Mn